Novo Holdings acquisition highlights growing pharma commercialization service market, says managing partner
Although it had made several investments in the clinical service market, this is the first time Novo Holdings has ventured into commercialization territory.
by albert rønning-andersson, translated by catherine brett
The smoke had barely lifted from the New Year fireworks when Novo Holdings announced its first acquisition of 2022 – US company Medical Knowledge Group (MKG).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
.jpg)
Novo Nordisk closes Dicerna acquisition deal
For subscribers
.jpg&w=384&q=75)
